As of April 19, 2025, TherapeuticsMD (TXMD) has a market cap of $11.648 million USD. According to our data, TherapeuticsMD is ranked No.8757 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $11.65 M |
17.44%
|
Dec 31, 2024 | $9.92 M |
-61.78%
|
Dec 29, 2023 | $25.95 M |
-59.75%
|
Dec 30, 2022 | $64.47 M |
-68.94%
|
Dec 31, 2021 | $0.21 B |
-70.25%
|
Dec 31, 2020 | $0.70 B |
-50.00%
|
Dec 31, 2019 | $1.40 B |
-36.48%
|
Dec 31, 2018 | $2.20 B |
-36.92%
|
Dec 29, 2017 | $3.48 B |
4.68%
|
Dec 30, 2016 | $3.33 B |
-44.36%
|
Dec 31, 2015 | $5.98 B |
133.03%
|
Dec 31, 2014 | $2.57 B |
-14.59%
|
Dec 31, 2013 | $3.00 B |
68.06%
|
Dec 31, 2012 | $1.79 B |
106.67%
|
Dec 30, 2011 | $0.86 B |
-50.00%
|
Dec 31, 2010 | $1.73 B |
-97.69%
|
Dec 31, 2009 | $74.96 B |
160.00%
|
Dec 31, 2008 | $28.83 B |
48.51%
|
Dec 31, 2007 | $19.41 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() AbbVie
ABBV
|
$306.02 B |
0.008 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
![]() UK
|
![]() AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
![]() UK
|
Market Cap | = | TXMD Stock Price | * | TXMD Shares Outstanding |
= | $1.01 | * | 11.53 M | |
= | $11.65 M |